Can we leverage tax policy to improve public health?
Professor Lawrence Summers and former New York Mayor Michael Bloomberg announce a new task force to identify underused fiscal tools to mitigate health and economic burdens of non-communicable diseases (NCDs) in low and moderate income countries.
Prescription drugs in the United States can be quite costly, for both the government and individuals. New research from HKS professor Richard Zeckhauser offers a new framework for lowering the prices that are paid for a few extremely costly drugs.
Related degree program courses
Introduction to U.S. Health Care Policy
SUP-500The aim of this course is to provide students with an overview of the U.S. health care system, its components, and the policy challenges created by the organization of the system.
Political Analysis and Strategy for U.S. Health Policy
SUP-575Health policymaking in the U.S. has a strong political dimension. This course offers analytical insights into understanding U.S. health policymaking and developing political strategies that influence health policy outcomes.
Core Course in Health Policy I
SUP-957This seminar is required for doctoral candidates in health policy and is open to others by permission of the instructor.
Experts at Harvard Kennedy School address the pressing policy questions posed by the well-publicized calls to repeal and reform the country’s health care system, as well as the Trump administration’s and Congress’s less clearly defined approach to other programs for the poor.